HPV self-testing and cervical cancer screening coverage
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A persistent HPV infection causes most cases of cervical cancer.
“A persistent infection with HPV causes most cases of cervical cancer; for many women who have an existing HPV infection or do not have access to HPV vaccination, improved screening for early detection and treatment remains the best option for reducing the cervical cancer burden [2].”
From A community‐based, cross‐sectional study of hr<scp>HPV DNA</scp> self‐sampling‐based cervical cancer screening in rural Karnataka, India (2019) · cites this paper as [2]
Cites
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M. A., Kulasingam, S., Cain, J. M., García, F., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,411 · see citing works
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674 · see citing works
Lazcano-Ponce, E., Lorincz, A. T., Cruz-Valdez, A., Salmerón, J., Uribe, P., Velasco-Mondragón, E., Nevarez, P. H., Acosta, R. D., & Hernández-Avila, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61522-5 · Cited by 230 · see citing works
Virtanen, A., Nieminen, P., Luostarinen, T., & Anttila, A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0307 · Cited by 132 · see citing works
Sancho-Garnier, H., Tamalet, C., Halfon, P., Léandri, F.-X., Retraite, L. L., Djoufelkit, K., Heid, P., Davies, P. O., & Piana, L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28283 · Cited by 125 · see citing works
Gravitt, P. E., Belinson, J. L., Salmeron, J., & Shah, K. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.25974 · Cited by 106 · see citing works
Self-citationBroberg, G., Gyrd‐Hansen, D., Jonasson, J. M., Ryd, M., Holtenman, M., Milsom, I., & Strander, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28545 · Cited by 101 · see citing works
Belinson, J. L., Hu, S., Niyazi, M., Pretorius, R. G., Wang, H., Chen, W., Smith, J. S., Li, J., Taddeo, F. J., Burchette, R. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25144 · Cited by 86 · see citing works
Broberg, G., Jonasson, J. M., Ellis, J., Gyrd‐Hansen, D., Anjemark, B., Glantz, A., Söderberg, L., Ryd, M., Holtenman, M., Milsom, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27985 · Cited by 48 · see citing works
The Peru Cervical Cancer Prevention Study (PERCAPS): The technology to make screening accessible
Levinson, K. L., Abuelo, C., Salmerón, J., Chyung, E., Zou, J., Belinson, S., Wang, G., Santos, C., Vallejos, C. S., & Belinson, J. L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.026 · Cited by 38 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Arrossi, S., Thouyaret, L., Herrero, R., Campanera, A., Magdaleno, A., Cuberli, M., Barletta, P., Laudi, R., & Orellana, L. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70354-7 · Cited by 217 · see citing works
Haguenoer, K., Sengchanh, S., Gaudy-Graffin, C., Boyard, J., Fontenay, R., Marret, H., Goudeau, A., Pigneaux de Laroche, N., Rusch, E., & Giraudeau, B. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.510 · Cited by 106 · see citing works
Campos, N. G., Castle, P. E., Wright, T. C., & Kim, J. J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29594 · Cited by 71 · see citing works
Brown, B. J., Poteat, T., Marg, L. Z., & Galea, J. T. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0142 · Cited by 57 · see citing works
Mapanga, W., Girdler‐Brown, B. V., Feresu, S. A., Chipato, T., & Singh, E. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0874-7 · Cited by 53 · see citing works
Vuyst, H. D., Franceschi, S., Plummer, M., Mugo, N., Sakr, S. R., Meijer, C. J. L. M., Heideman, D. A. M., Tenet, V., Snijders, P. J. F., Hesselink, A. T., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000744 · Cited by 52 · see citing works
Viviano, M., DeBeaudrap, P., Tebeu, P.-M., Tsuala Fouogue, J., Vassilakos, P., & Petignat, P. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s103868 · Cited by 42 · see citing works
Innovative approaches to cervical cancer screening in low- and middle-income countries
Toliman, P. J., Kaldor, J. M., Tabrizi, S. N., & Vallely, A. J. (2018) · Climacteric · doi:10.1080/13697137.2018.1439917 · Cited by 39 · see citing works
Mbulawa, Z. Z. A., Somdyala, N. I. M., Mabunda, S. A., & Williamson, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253074 · Cited by 36 · see citing works
Poli, U. R., Muwonge, R., Bhoopal, T., Lucas, E., & Basu, P. S. (2020) · JCO Global Oncology · doi:10.1200/go.20.00061 · Cited by 28 · see citing works
Adsul, P., Srinivas, V., Gowda, S., Nayaka, S., Pramathesh, R., Chandrappa, K., Khan, A., Jayakrishna, P., & Madhivanan, P. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12859 · Cited by 23 · see citing works
Wang, X., Lin, Y., & Liu, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9729 · Cited by 20 · see citing works
Song, F., Du, H., Wang, C., Huang, X., Qu, X., Wei, L., Belinson, J. L., Wu, R., & CHIMUST team (2020) · Journal of Medical Screening · doi:10.1177/0969141320943634 · Cited by 16 · see citing works
Cora‐Cruz, M. S., Martínez, O., Perez, S., & Fang, C. Y. (2024) · Cancer Medicine · doi:10.1002/cam4.70098 · Cited by 8 · see citing works
Evaluation of Folate Receptor-Mediated Cervical Dyeing as a Method for Detection of Cervical Lesions
Zhao, Y., Li, M., Li, Y., Lv, Q., Chen, F., Li, B., Zhang, Z., Guo, H., Lu, D., Wang, F., et al. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000411 · Cited by 7 · see citing works
Application an internet facilitation in a community-based cervical cancer screening project
Du, H., Qu, X., Wang, G., Guo, C., Wang, Z., Min, J., Liu, Z., Hu, Q., Luo, H., Wang, C., et al. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02733-1 · Cited by 4 · see citing works
Evaluation of folate receptor‐mediated tumor detection as a triage tool in cervical cancer screening
Zhao, Y., Li, M., Li, Y., Lv, Q., Chen, F., Li, B., Zhang, Z., Guo, H., Lu, D., Wang, F., et al. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13245 · Cited by 4 · see citing works
Cervical Screening: History, Current Algorithms, and Future Directions
Smith, J. H. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-51257-0_3 · Cited by 3 · see citing works
Mbodi, L., Bassa, S., Kgoebane-Maseko, M., Adeola, H. A., Mehrotra, R., & Dlamini, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-36461-7_6
- Authors
- Gravitt, P. E., & Rositch, A. F.
- Affiliations
- University of New Mexico (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Gravitt, Patti E
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 15
- Issue
- 2
- Pages
- 128-129
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2152615221
- Cited by
- 19
- References
- 11
- Citations by year
- 2024: 1 · 2023: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 3 · 2015: 3 · 2014: 1
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- HPV self-testing, cervical cancer screening, HPV testing, self-collected samples, clinician-collected samples, Pap smear cytology, cervical intraepithelial neoplasia, screening sensitivity, screening coverage, screening programs, resource-limited settings, cervical cancer prevention, cervical cancer mortality reduction
- MeSH terms
- Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female, Humans, Mass Screening, Self Care, Specimen Handling, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review